AWM Investment Company’s Crinetics Pharmaceuticals CRNX Stock Holding History

AWM Investment Company’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.18M	Sell	85,000 -15,000	-15%	-$558K	0.28%	70
2026 Q1	$3.63M	Hold	100,000	–	–	0.4%	59
2025 Q4	$4.66M	Hold	100,000	–	–	0.45%	63
2025 Q3	$4.17M	Buy	100,000 +5,000	+5%	+$160K	0.39%	63
2025 Q2	$2.73M	Hold	95,000	–	–	0.31%	73
2025 Q1	$3.19M	Buy	95,000 +40,000	+73%	+$1.49M	0.44%	59
2024 Q4	$2.81M	Hold	55,000	–	–	0.34%	60
2024 Q3	$2.81M	Hold	55,000	–	–	0.34%	63
2024 Q2	$2.46M	Hold	55,000	–	–	0.33%	64
2024 Q1	$2.57M	Buy	55,000 +5,000	+10%	+$196K	0.34%	64
2023 Q4	$1.78M	Buy	50,000 +35,000	+233%	+$1.07M	0.23%	77
2023 Q3	$446K	Buy	+15,000	New	+$309K	0.07%	96

Other funds holding CRNX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jupiter Topco New York $245B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AWM Investment Company's CRNX Position: Q2 2026 in Review

AWM Investment Company reduced its Crinetics Pharmaceuticals (CRNX) stake by 15% in Q2 2026, selling an estimated $558K and leaving 85,000 shares worth $3.18M. The position accounts for 0.28% of the portfolio, ranked #70.

AWM Investment Company first reported a position in CRNX in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.66M in Q4 2025. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

AWM Investment Company held 85,000 shares of Crinetics Pharmaceuticals worth $3.18M as of Q2 2026.
AWM Investment Company sold 15,000 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $558K.
Crinetics Pharmaceuticals made up 0.28% of AWM Investment Company's portfolio in Q2 2026, its #70 holding.
AWM Investment Company first reported a position in Crinetics Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
AWM Investment Company's Crinetics Pharmaceuticals position peaked at $4.66M in Q4 2025.
267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on AWM Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.